mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.03 |
mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.03 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.03 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.03 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.03 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.04 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.04 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.04 |